ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,814.00
      -0.16%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.615
      -0.86%
      Bitcoin
      62,511.61
      -3.59%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ImmunoGen Inc (IMGN)

      7. ImmunoGen Inc (IMGN) News

      IMGN

      ImmunoGen (IMGN)

      ImmunoGen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IMGN
      DateTimeSourceHeadlineSymbolCompany
      02/12/20244:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20244:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20244:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20244:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20244:19PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20244:19PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20244:17PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
      02/12/20249:32AMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:IMGNImmunoGen Inc
      02/12/20247:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMGNImmunoGen Inc
      02/12/20247:37AMPR Newswire (US)AbbVie Completes Acquisition of ImmunoGenNASDAQ:IMGNImmunoGen Inc
      02/08/20247:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMGNImmunoGen Inc
      02/07/20247:56AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMGNImmunoGen Inc
      02/06/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/06/20249:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/06/20249:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/06/20249:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20249:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20244:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20244:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20244:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMGNImmunoGen Inc
      02/05/20244:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMGNImmunoGen Inc
      02/01/20244:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
      01/31/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMGNImmunoGen Inc
       Showing the most relevant articles for your search:NASDAQ:IMGN